183 related articles for article (PubMed ID: 21437226)
1. Novel prophylactic vaccine using a prime-boost method and hemagglutinating virus of Japan-envelope against tuberculosis.
Okada M; Kita Y; Nakajima T; Kanamaru N; Hashimoto S; Nagasawa T; Kaneda Y; Yoshida S; Nishida Y; Nakatani H; Takao K; Kishigami C; Nishimatsu S; Sekine Y; Inoue Y; McMurray DN; Sakatani M
Clin Dev Immunol; 2011; 2011():549281. PubMed ID: 21437226
[TBL] [Abstract][Full Text] [Related]
2. Development of therapeutic and prophylactic vaccine against Tuberculosis using monkey and transgenic mice models.
Kita Y; Okada M; Nakajima T; Kanamaru N; Hashimoto S; Nagasawa T; Kaneda Y; Yoshida S; Nishida Y; Nakatani H; Takao K; Kishigami C; Nishimatsu S; Sekine Y; Takamori Y; McMurray DN; De la Cruz EC; Tan EV; Abalos RM; Burgos JA; Saunderson P; Sakatani M
Hum Vaccin; 2011; 7 Suppl():108-14. PubMed ID: 21263229
[TBL] [Abstract][Full Text] [Related]
3. DNA vaccine using hemagglutinating virus of Japan-liposome encapsulating combination encoding mycobacterial heat shock protein 65 and interleukin-12 confers protection against Mycobacterium tuberculosis by T cell activation.
Yoshida S; Tanaka T; Kita Y; Kuwayama S; Kanamaru N; Muraki Y; Hashimoto S; Inoue Y; Sakatani M; Kobayashi E; Kaneda Y; Okada M
Vaccine; 2006 Feb; 24(8):1191-204. PubMed ID: 16216394
[TBL] [Abstract][Full Text] [Related]
4. The study of novel DNA vaccines against tuberculosis: induction of pathogen-specific CTL in the mouse and monkey models of tuberculosis.
Okada M; Kita Y; Nakajima T; Hashimoto S; Nakatani H; Nishimatsu S; Nishida Y; Kanamaru N; Kaneda Y; Takamori Y; McMurray D; Tan EV; Cang ML; Saunderson P; Dela Cruz EC
Hum Vaccin Immunother; 2013 Mar; 9(3):515-25. PubMed ID: 23249543
[TBL] [Abstract][Full Text] [Related]
5. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
6. Sendai Virus Mucosal Vaccination Establishes Lung-Resident Memory CD8 T Cell Immunity and Boosts BCG-Primed Protection against TB in Mice.
Hu Z; Wong KW; Zhao HM; Wen HL; Ji P; Ma H; Wu K; Lu SH; Li F; Li ZM; Shu T; Xu JQ; Lowrie DB; Fan XY
Mol Ther; 2017 May; 25(5):1222-1233. PubMed ID: 28342639
[TBL] [Abstract][Full Text] [Related]
7. [Recent progress in mycobacteriology].
Okada M; Kobayashi K
Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
[TBL] [Abstract][Full Text] [Related]
8. Novel recombinant BCG and DNA-vaccination against tuberculosis in a cynomolgus monkey model.
Kita Y; Tanaka T; Yoshida S; Ohara N; Kaneda Y; Kuwayama S; Muraki Y; Kanamaru N; Hashimoto S; Takai H; Okada C; Fukunaga Y; Sakaguchi Y; Furukawa I; Yamada K; Inoue Y; Takemoto Y; Naito M; Yamada T; Matsumoto M; McMurray DN; Cruz EC; Tan EV; Abalos RM; Burgos JA; Gelber R; Skeiky Y; Reed S; Sakatani M; Okada M
Vaccine; 2005 Mar; 23(17-18):2132-5. PubMed ID: 15755583
[TBL] [Abstract][Full Text] [Related]
9. Heterologous Boost Following
Wu Y; Cai M; Ma J; Teng X; Tian M; Bassuoney EBMB; Fan X
Front Immunol; 2018; 9():2439. PubMed ID: 30425711
[TBL] [Abstract][Full Text] [Related]
10. Novel prophylactic and therapeutic vaccine against tuberculosis.
Okada M; Kita Y; Nakajima T; Kanamaru N; Hashimoto S; Nagasawa T; Kaneda Y; Yoshida S; Nishida Y; Nakatani H; Takao K; Kishigami C; Inoue Y; Matsumoto M; McMurray DN; Dela Cruz EC; Tan EV; Abalos RM; Burgos JA; Saunderson P; Sakatani M
Vaccine; 2009 May; 27(25-26):3267-70. PubMed ID: 19200841
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity and protective efficacy against murine tuberculosis of a prime-boost regimen with BCG and a DNA vaccine expressing ESAT-6 and Ag85A fusion protein.
Lu J; Wang C; Zhou Z; Zhang Y; Cao T; Shi C; Chen Z; Chen L; Cai C; Fan X
Clin Dev Immunol; 2011; 2011():617892. PubMed ID: 21461375
[TBL] [Abstract][Full Text] [Related]
12. [The development of novel vaccines against tuberculosis].
Okada M
Nihon Rinsho Meneki Gakkai Kaishi; 2008 Oct; 31(5):356-68. PubMed ID: 18974619
[TBL] [Abstract][Full Text] [Related]
13. [Anti-tuberculosis immunity by cytotoxic T cells * granulysin and the development of novel vaccines (HSP-65 DNA+IL-12 DNA)].
Okada M; Kita Y
Kekkaku; 2010 Jun; 85(6):531-8. PubMed ID: 20662249
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a novel vaccine (HVJ-liposome/HSP65 DNA+IL-12 DNA) against tuberculosis using the cynomolgus monkey model of TB.
Okada M; Kita Y; Nakajima T; Kanamaru N; Hashimoto S; Nagasawa T; Kaneda Y; Yoshida S; Nishida Y; Fukamizu R; Tsunai Y; Inoue R; Nakatani H; Namie Y; Yamada J; Takao K; Asai R; Asaki R; Matsumoto M; McMurray DN; Dela Cruz EC; Tan EV; Abalos RM; Burgos JA; Gelber R; Sakatani M
Vaccine; 2007 Apr; 25(16):2990-3. PubMed ID: 17280753
[TBL] [Abstract][Full Text] [Related]
15. Heterologous prime-boost vaccination against tuberculosis with recombinant Sendai virus and DNA vaccines.
Hu Z; Jiang W; Gu L; Qiao D; Shu T; Lowrie DB; Lu SH; Fan XY
J Mol Med (Berl); 2019 Dec; 97(12):1685-1694. PubMed ID: 31786669
[TBL] [Abstract][Full Text] [Related]
16. Prime-boost vaccination with Bacillus Calmette Guerin and a recombinant adenovirus co-expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium tuberculosis induces robust antigen-specific immune responses in mice.
Li W; Li M; Deng G; Zhao L; Liu X; Wang Y
Mol Med Rep; 2015 Aug; 12(2):3073-80. PubMed ID: 25962477
[TBL] [Abstract][Full Text] [Related]
17. Novel therapeutic vaccines [(HSP65 + IL-12)DNA-, granulysin- and Ksp37-vaccine] against tuberculosis and synergistic effects in the combination with chemotherapy.
Kita Y; Hashimoto S; Nakajima T; Nakatani H; Nishimatsu S; Nishida Y; Kanamaru N; Kaneda Y; Takamori Y; McMurray D; Tan EV; Cang ML; Saunderson P; Dela Cruz EC; Okada M
Hum Vaccin Immunother; 2013 Mar; 9(3):526-33. PubMed ID: 23249609
[TBL] [Abstract][Full Text] [Related]
18. Prime-boost BCG vaccination with DNA vaccines based in β-defensin-2 and mycobacterial antigens ESAT6 or Ag85B improve protection in a tuberculosis experimental model.
Cervantes-Villagrana AR; Hernández-Pando R; Biragyn A; Castañeda-Delgado J; Bodogai M; Martínez-Fierro M; Sada E; Trujillo V; Enciso-Moreno A; Rivas-Santiago B
Vaccine; 2013 Jan; 31(4):676-84. PubMed ID: 23196205
[TBL] [Abstract][Full Text] [Related]
19. Novel therapeutic vaccine: granulysin and new DNA vaccine against Tuberculosis.
Okada M; Kita Y; Nakajima T; Kanamaru N; Hashimoto S; Nagasawa T; Kaneda Y; Yoshida S; Nishida Y; Nakatani H; Takao K; Kishigami C; Nishimatsu S; Sekine Y; Inoue Y; Matsumoto M; McMurray DN; De la Cruz EC; Tan EV; Abalos RM; Burgos JA; Saunderson P; Sakatani M
Hum Vaccin; 2011; 7 Suppl():60-7. PubMed ID: 21546794
[TBL] [Abstract][Full Text] [Related]
20. Protection against Mycobacterium tuberculosis infection offered by a new multistage subunit vaccine correlates with increased number of IFN-γ+ IL-2+ CD4+ and IFN-γ+ CD8+ T cells.
Wang X; Zhang J; Liang J; Zhang Y; Teng X; Yuan X; Fan X
PLoS One; 2015; 10(3):e0122560. PubMed ID: 25822536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
